Definition for the Assessment of Time-to-event Endpoints in CANcer trials(English)

• aims to provide recommendations for definitions of TTE end points using a formal consensus process for multiple cancer sites: breast; sarcomas/GISTs; pancreas; stomach/esophagus; head and neck; colon/rectum; kidney/bladder; and lung cancers
• RCT, TTE, GIST
• Clinical trials, Oncology
• https://doi.org…3/annonc/mdv106